Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report

BACKGROUND: Interleukin-17 (IL-17) inhibitors are known to cause exacerbation or new onset of inflammatory bowel disease upon administration. However, few reports have described characteristic endoscopic and histopathologic findings, and no small intestinal lesions have been reported so far. CASE SU...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Keita, Yoza, Kiichiro, Takeda, Shinichiro, Shimoyama, Yoshihiro, Takeuchi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494761/
https://www.ncbi.nlm.nih.gov/pubmed/37701132
http://dx.doi.org/10.3748/wjg.v29.i32.4912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494761/
https://www.ncbi.nlm.nih.gov/pubmed/37701132
http://dx.doi.org/10.3748/wjg.v29.i32.4912

Ejemplares similares